Published in Curr Allergy Asthma Rep on May 01, 2006
Aspirin allergy desensitization in cerebrovascular disease. A report of two cases, literature review and management guide for the neurointerventionalist. Interv Neuroradiol (2014) 0.75
Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease: an evidence-based review with recommendations. Int Forum Allergy Rhinol (2016) 0.75
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol (2010) 2.98
The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complex. J Cell Biol (2005) 2.04
Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper. Ann Allergy Asthma Immunol (2007) 1.77
The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2005) 1.69
Food allergy: a practice parameter update-2014. J Allergy Clin Immunol (2014) 1.60
The j-subunit of human translation initiation factor eIF3 is required for the stable binding of eIF3 and its subcomplexes to 40 S ribosomal subunits in vitro. J Biol Chem (2003) 1.57
Excess dampness and mold growth in homes: an evidence-based review of the aeroirritant effect and its potential causes. Allergy Asthma Proc (2007) 1.51
Pulse steroid therapy inhibits murine subglottic granulation. Otolaryngol Head Neck Surg (2012) 1.38
The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2002) 1.14
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. Nutr Res (2011) 1.14
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2003) 1.12
The safety of celecoxib in patients with aspirin-sensitive asthma. Arthritis Rheum (2002) 1.09
Somatic mutations of PIK3R1 promote gliomagenesis. PLoS One (2012) 1.06
Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2006) 1.00
The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis. Am J Rhinol Allergy (2012) 0.98
Aspirin sensitivity: implications for patients with coronary artery disease. JAMA (2004) 0.97
Effect of leukotriene modifier drugs on the safety of oral aspirin challenges. Ann Allergy Asthma Immunol (2006) 0.96
Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis. Ann Allergy Asthma Immunol (2008) 0.95
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report. Nutrition (2011) 0.92
Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol (2006) 0.90
Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2003) 0.87
Localization in stereocilia, plasma membrane, and mitochondria suggests diverse roles for NMHC-IIa within cochlear hair cells. Brain Res (2008) 0.87
Sphenoid sinus anatomy and suprasellar extension of pituitary tumors. J Neurosurg (2013) 0.86
Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2010) 0.86
Bilateral silent sinus syndrome. Ear Nose Throat J (2012) 0.86
Sensitivity to nonsteroidal anti-inflammatory drugs. Ann Allergy Asthma Immunol (2002) 0.86
Aspirin-exacerbated respiratory disease: burden of disease. Allergy Asthma Proc (2012) 0.85
Haplotype structures and large-scale association testing of the 5' AMP-activated protein kinase genes PRKAA2, PRKAB1, and PRKAB2 [corrected] with type 2 diabetes. Diabetes (2006) 0.85
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel report. J Am Acad Dermatol (2011) 0.85
Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2008) 0.85
The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges. J Allergy Clin Immunol (2007) 0.83
Clopidogrel desensitization after drug-eluting stent placement. J Am Coll Cardiol (2007) 0.83
Inflammatory protein expression in human subglottic stenosis tissue mirrors that in a murine model. Ann Otol Rhinol Laryngol (2014) 0.83
18-FDG-PET in the initial staging of sinonasal malignancy. Laryngoscope (2013) 0.80
Cardiovascular prophylaxis and aspirin "allergy". Immunol Allergy Clin North Am (2012) 0.78
Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2004) 0.78
The Difficult-to-Control Asthmatic: A Systematic Approach. Allergy Asthma Clin Immunol (2006) 0.77
Supraesophageal reflux disease: a review of the literature. Allergy Asthma Proc (2014) 0.77
Making the call: the diagnosis of acute community-acquired bacterial sinusitis. Am J Rhinol (2006) 0.77
Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2005) 0.76
Aspirin as a cause of pancreatitis in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2012) 0.76
Cross-reactivity of cyclooxygenase 2 inhibitors in patients with a history of cutaneous reactions to cyclooxygenase 1 inhibitors. Ann Allergy Asthma Immunol (2005) 0.75
Evidence-based protocols for oral NSAID challenges. J Pediatr (2006) 0.75
Aspirin-exacerbated respiratory disease: is it in our DNA? Ann Allergy Asthma Immunol (2011) 0.75
Nasal congestion, postnasal drip, and aural fullness. JAMA Otolaryngol Head Neck Surg (2013) 0.75
Assessment of sensitization risk of a laundry pre-spotter containing protease. Cutan Ocul Toxicol (2011) 0.75
Macrolide antibiotics as anti-inflammatory agents. Curr Allergy Asthma Rep (2005) 0.75
Sinusitis and chronic progressive exercise-induced cough and dyspnea. Allergy Asthma Proc (2009) 0.75
Approach to patients with aspirin hypersensitivity and acute cardiovascular emergencies. Allergy Asthma Proc (2013) 0.75